Dacarbazine
NDC 71288-174, Dacarbazine, injection, powder, for solution, from Meitheal Pharmaceuticals Inc..
- Product NDC
- 71288-174
- Status
- Listed
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075259
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71288-174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DACARBAZINE200 mg/20mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71288-174-21 | 71288017421 | 10 VIAL, SINGLE-USE in 1 CARTON (71288-174-21) / 20 mL in 1 VIAL, SINGLE-USE (71288-174-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/64037f45-6245-49f0-9ae8-18d75753ae1fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71288-174
Use it
Look up 71288-174 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71288-174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71288-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.